Eight-year follow-up study of brain atrophy in patients with MS von FISHER, E, RUDICK, R. A, SIMONIAN, N. A, SIMON, J. H, CUTTER, G, BAIER, M, LEE, J.-C, MILLER, D, WEINSTOCK-GUTTMAN, B, MASS, M. K, DOUGHERTY, D. S

Volltext

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphob... von Caye, Aurélie, Beldjord, Kheïra, Mass-Malo, Kelly, Drunat, Séverine, Soulier, Jean, Gandemer, Virginie, Baruchel, André, Bertrand, Yves, Cavé, Hélène, Clappier, Emmanuelle

Volltext

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study von Solomon, Andrew J, Bourdette, Dennis N, Cross, Anne H, Applebee, Angela, Skidd, Philip M, Howard, Diantha B, Spain, Rebecca I, Cameron, Michelle H, Kim, Edward, Mass, Michele K, Yadav, Vijayshree, Whitham, Ruth H, Longbrake, Erin E, Naismith, Robert T, Wu, Gregory F, Parks, Becky J, Wingerchuk, Dean M, Rabin, Brian L, Toledano, Michel, Tobin, W Oliver, Kantarci, Orhun H, Carter, Jonathan L, Keegan, B Mark, Weinshenker, Brian G

Volltext

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis von Jacobs, Lawrence D., Cookfair, Diane L., Rudick, Richard A., Herndon, Robert M., Richert, John R., Salazar, Andres M., Fischer, Jill S., Goodkin, Donald E., Granger, Carl V., Simon, Jack H., Alam, John J., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munschauer III, Frederick E., Priore, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Weinstock-Guttman, Bianca, Whitham, Ruth H.

Volltext

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis von RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Volltext

Use of the multiple sclerosis Functional Composite to predict disability in relapsing MS von RUDICK, R. A, CUTTER, G, BAIER, M, FISHER, E, DOUGHERTY, D, WEINSTOCK-GUTTMAN, B, MASS, M. K, MILLER, D, SIMONIAN, N. A

Volltext

Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients von Rudick, R A, Cutter, G R, Baier, M, Weinstock-Guttman, B, Mass, M K, Fisher, E, Miller, D M, Sandrock, A W

Volltext

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients von Fisher, E., Rudick, R.A., Cutter, G., Baier, M., Miller, D., Weinstock-Guttman, B., Mass, M.K., Dougherty, D.S., Simonian, N.A.

Volltext

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis von Herndon, Robert M, Rudick, Richard A, Munschauer, Frederick E, Mass, Michele K, Salazar, Andres M, Coats, Michael E, Labutta, Robert, Richert, John R, Cohan, Stanley L, Genain, Claude, Goodkin, Donald, Toal, Martin, Riester, Katherine

Volltext

Demonstration of environmentally sound and cost-effective shipping von Krozer, J., Mass, K., Kothuis, B.

Volltext

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis von RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Volltext

Factors that predict health-related Quality of Life in patients with relapsing-remitting multiple sclerosis von MILLER, Deborah M, RUDICK, Richard A, BAIER, Monika, CUTTER, Gary, DOUGHTERY, David S, WEINSTOCK-GUTTMAN, Bianca, MASS, Michele K, FISHER, Elizabeth, SIMONIAN, Nancy

Volltext

Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis von Simon, Jack H., Jacobs, Lawrence D., Campion, Marilyn, Wende, Karl, Simonian, Nancy, Cookfair, Diane L., Rudick, Richard A., Herndon, Robert M., Richert, John R., Salazar, Andres M., Alam, John J., Fischer, Jill S., Goodkin, Donald E., Granger, Carl V., Lajaunie, Michelle, Martens-Davidson, Anna L., Meyer, Maryjoel, Sheeder, Jeanelle, Choi, Kim, Scherzinger, Ann L., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munschauer III, Fredrick E., Priore Scd, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Weinstock-Guttman, Bianca, Whitham, Ruth H.

Volltext

The MLL recombinome of acute leukemias in 2013 von Meyer, C, Hofmann, J, Burmeister, T, Gröger, D, Park, T S, Emerenciano, M, Pombo de Oliveira, M, Renneville, A, Villarese, P, Macintyre, E, Cavé, H, Clappier, E, Mass-Malo, K, Zuna, J, Trka, J, De Braekeleer, E, De Braekeleer, M, Oh, S H, Tsaur, G, Fechina, L, van der Velden, V H J, van Dongen, J J M, Delabesse, E, Binato, R, Silva, M L M, Kustanovich, A, Aleinikova, O, Harris, M H, Lund-Aho, T, Juvonen, V, Heidenreich, O, Vormoor, J, Choi, W W L, Jarosova, M, Kolenova, A, Bueno, C, Menendez, P, Wehner, S, Eckert, C, Talmant, P, Tondeur, S, Lippert, E, Launay, E, Henry, C, Ballerini, P, Lapillone, H, Callanan, M B, Cayuela, J M, Herbaux, C, Cazzaniga, G, Kakadiya, P M, Bohlander, S, Ahlmann, M, Choi, J R, Gameiro, P, Lee, D S, Krauter, J, Cornillet-Lefebvre, P, Te Kronnie, G, Schäfer, B W, Kubetzko, S, Alonso, C N, zur Stadt, U, Sutton, R, Venn, N C, Izraeli, S, Trakhtenbrot, L, Madsen, H O, Archer, P, Hancock, J, Cerveira, N, Teixeira, M R, Lo Nigro, L, Möricke, A, Stanulla, M, Schrappe, M, Sedék, L, Szczepański, T, Zwaan, C M, Coenen, E A, van den Heuvel-Eibrink, M M, Strehl, S, Dworzak, M, Panzer-Grümayer, R, Dingermann, T, Klingebiel, T, Marschalek, R

Volltext

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis von Goodman, Andrew D., Brown, Theodore R., Edwards, Keith R., Krupp, Lauren B., Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N., Blight, Andrew R.

Volltext

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial von Goodman, Andrew D, Prof, Brown, Theodore R, MD, Krupp, Lauren B, MD, Schapiro, Randall T, MD, Schwid, Steven R, MD, Cohen, Ron, MD, Marinucci, Lawrence N, MS, Blight, Andrew R, PhD

Volltext

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis: Multiple sclerosis von RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Volltext

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials von Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R, Agius, M, Arnason, BGW, Bethoux, FA, Bever, CT, Bowen, JD, Brown, TR, Dietrich, DW, Edwards, K, Freedman, MS, Freedman, M, Kachuck, NJ, Kaufman, MD, Keilson, M, Khan, O, Krupp, LB, Leist, TP, Lindsey, JW, Lublin, FD, Mass, MK, Mattson, D, McGowan, D, Naismith, R, O’Connell, C, Oger, JJ, Panitch, H, Picone, MA, Rammohan, KW, Schapiro, RT, Schwid, SR, Scott, T, Short, C, Thrower, BW, Vollmer, TL, Camac, A, Cooper, JA, Chumley, WF, Cross, A, Dunnigan, RT, Gitt, JS, Hillen, M, Jeffrey, DR, Khatri, BO, Kresa-Reahl, K, Moon, S, Preiningerova, J, Tullman, M, Weinstock-Guttman, B, Wynn, DR

Volltext

Dose comparison trial of sustained-release fampridine in multiple sclerosis von GOODMAN, A. D, BROWN, T. R, COHEN, J. A, KRUPP, L. B, SCHAPIRO, R, SCHWID, S. R, COHEN, R, MARINUCCI, L. N, BLIGHT, A. R

Volltext

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials von Goodkin, D E, Priore, R L, Wende, K E, Campion, M, Bourdette, D N, Herndon, R M, Fischer, J S, Jacobs, L D, Cookfair, D L, Rudick, R A, Richert, J R, Salazar, A M, Granger, C V, Simon, J H, Alam, J J, Bartoszak, D M, Braiman, J, Brownscheidle, C M, Coats, M E, Cohan, S L, Dougherty, D S, Kinke, R P, Mass, M K, Munschauer, F E, Pullicino, P M, Scherokman, B J, Weinstock-Guttman, B, Whitham, R H

Volltext